Overview

The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users

Status:
Active, not recruiting
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
A prospective, non-inferiority study to evaluate the pharmacokinetic effect of topiramate on serum Etonogestrel (ENG) levels in contraceptive implant users.
Phase:
Phase 1
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Contraceptive Agents
Etonogestrel
Topiramate